Oncology & Cancer

Novel immunotherapy trial for lymphoma offers hope to patients

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have ...

Other

Survival benefit for kidneys from incompatible living donors

(HealthDay)—In what researchers are calling a possible "paradigm shift," a new study shows kidney disease patients may live longer if they receive a transplant from an incompatible living donor rather than wait for a good ...

Other

Moderate costs incurred by living kidney donors

(HealthDay)—Living kidney donors (LKDs) incur moderate costs related to the completion of donation evaluation, according to a study published online May 5 in the American Journal of Transplantation.

page 5 from 10